FHTX

Conviction 86HealthcareScan · Mon, Aug 10, 2026

FHTX$6.25+2.88%

ResistanceSupportVol 14

Vol MA14 274.66K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Foghorn Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.foghorntx.com ↗

Price6.25

Change+2.88%

Gap+1.98%

Rel volume6.23×

Avg volume280.38K

Avg $ vol1.52M

SMA 205.16

SMA 504.75

SMA 2004.91

Price vs 50+31.50%

Price vs 200+27.09%

MA stackmixed

50/200 cross—

Supertrendup · 4.99

RSI (14)69

MACD hist0.10

MACD crossbull · 1d

Stoch %K / %D84 / 93

ADX (14)24

+DI / −DI39 / 14

RSI divergence—

MACD divergence—

ATR %+6.53%

ADR %6.92%

52w high6.68

52w low3.53

From 52w high-6.51%

Above 52w low+76.91%

New 52w highNo

SqueezeOff

Bollinger width33.11%

%B1.14

Donchian pos84.21%

Donchian high6.59

Donchian low4.41

AVWAP (52w high)5.13

vs AVWAP high+21.77%

AVWAP (52w low)5.04

vs AVWAP low+23.84%

OBV trendUp

Chaikin MF (20)0.11

Today vs 20d6.23×

Avg vol (14d)274.66K

Avg vol (20d)280.38K

Avg $ vol (20d)1.52M

Market cap—

RS 3m (vs SPY)+38.83%

RS 6m (vs SPY)+1.95%

RS line new highNo

Trend template7/8

Technical rank87.2

1 week+35.47%

1 month+4.96%

3 months+40.65%

6 months+9.95%

1 year+25.40%

YTD+20.33%

P/E-4.84

P/B-4.44

P/S11.63

P/FCF-4.17

EPS-1.18

Div yield—

ROE91.66%

ROA-36.52%

Debt/Eq0.00

Current3.36

EV/EBITDA-3.51

Gross margin—

Net margin-240.33%

Rev growth36.75%

EPS growth14.24%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value291.5M

Revenue16.07M

Net income-7.19M

Gross profit—

Free cash flow-86.15M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out58.71M

Employees106

ListedFri, Oct 23, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction86 / 100

Pattern quality—

Tech rank87.2 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.91

Support3.97

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FHTX

All disclosures →

No recent disclosed trades by Congress in FHTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FHTX · 10 buys

Insider	Side	Shares	Value	Traded	Filed
SMITH IAN F Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
Biller Scott Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
Cole Douglas G. Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
Duty Stuart Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
PARSHALL B LYNNE Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
Lynch Thomas J. Jr. Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
Mendelsohn Michael Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
Gallagher Neil Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
GILL SIMBA Director · Stock Options (Right to buy) · 2026-06-24	Grant	28K	$114K	2026-06-24	2026-06-25
GOTTSCHALK ADRIAN Chief Executive Officer · Common Stock · 2026-04-10	Gift	59.21K	$0	2026-04-10	2026-04-13

SEC filings

EDGAR filings in FHTX · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.